Zantac Investor Class Action Time-Barred, Pa. Judge Rules
By Jonathan Capriel · March 4, 2026, 7:34 PM EST
The maker of heartburn and acid reflux relief tablet Zantac has defeated a securities fraud class action claiming the company hid for decades the cancer risks associated with the drug, causing...
To view the full article, register now.